Literature DB >> 3046002

Upper-extremity vascular injuries.

R A McCready1.   

Abstract

Although upper-extremity injuries alone are usually not life-threatening, they can produce significant immediate or long-term morbidity, especially if there is an associated nerve injury. The diagnosis of an arterial injury may be readily apparent, but the excellent upper-extremity collateral circulation may create palpable distal pulses despite a significant proximal arterial injury. Therefore, a high index of suspicion and the liberal use of arteriography are necessary to avoid missing these injuries. Compression of the brachial plexus by a hematoma can produce a serious neurologic deficit. Prompt evacuation of the hematoma may significantly reduce the deficit, another fact that supports an aggressive surgical approach in these patients. The long-term results of upper-extremity vascular injuries are usually determined by the extent of any associated nerve injuries.

Entities:  

Mesh:

Year:  1988        PMID: 3046002     DOI: 10.1016/s0039-6109(16)44582-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  [Inner amputation of an upper extremity with impaired cerebral perfusion and lethal outcome].

Authors:  M Wille; A Bölderl; M Blauth; B Friesenecker
Journal:  Unfallchirurg       Date:  2006-07       Impact factor: 1.000

Review 2.  Roles of Trauma CT and CTA in Salvaging the Threatened or Mangled Extremity.

Authors:  David Dreizin; Elana B Smith; Kathryn Champ; Jonathan J Morrison
Journal:  Radiographics       Date:  2022 Mar-Apr       Impact factor: 5.333

3.  Delayed Onset of Subclavian Artery Pseudoaneurysm With Brachial Plexus Compression Following Gunshot Wound Injury.

Authors:  Thomas Huang; Clayton W Armstrong; Geoffrey D Panjeton
Journal:  Cureus       Date:  2022-02-21

4.  Management of traumatic brachial artery injuries: a report on 49 patients.

Authors:  Hasan Ekim; Mustafa Tuncer
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.